HCA Healthcare, Inc. (HCA) Stock: Price, Forecast & Analyst Target
HCA Healthcare, Inc. (HCA) — MoonshotScore 83/100 (Exceptional band), calculated Oct 4, 2026. Price $426.69 (+0.78%), as of the Oct 2, 2026 trading session; market cap $92.4B. Expected results Oct 23, 2026.
Educational signal · not a buy or sell recommendation · How to read this
Market value / cash and short-term investments: 91.21× (market value Oct 2, 2026; cash Jun 30, 2026) · expected results Oct 23, 2026
HCA Healthcare, Inc. · HCA · NYSE · Healthcare · Medical - Care Facilities
Research dated 2026-09-12: HCA Healthcare delivers hospital and outpatient care across a broad clinical network, collecting revenue from commercial insurers and government programs rather than selling insurance itself. Patient activity and outpatient expansion must keep lifting operating profit while a debt-heavy capital structure limits tolerance for execution setbacks.
Price as of Oct 2, 2026
Key Statistics
MoonshotScore v2 · HCA Healthcare (HCA)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality and elite growth, at a cheap price, though the balance sheet is only decent. Business Quality: Solid; Financial Safety: Okay; Valuation: Cheap; Growth Durability: Compounding; Momentum: Rising.
- quarterly revenue $20.23B (Q2 FY2026, quarter ended Jun 2026)
- EPS beat 5 of 8
- expected results Oct 23, 2026
Helping: business quality, an attractive price, durable growth
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 82 | Exceptional | |
| 82 | Exceptional | |
| 82 | Exceptional | |
| 82 | Exceptional | |
| 83 | Exceptional | |
| 83 | Exceptional |
The score was 83 in the stored Oct 3, 2026 snapshot and remains 83 in the current publication computed Oct 4, 2026 (0); the largest pillar moves were Momentum +1; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $426.69 | |
| Change on the day | +0.78% | |
| 52-week range | $353.99 – $556.52 | |
| Market capitalisation | $92.4B | |
| Price / earnings (trailing) | 14.24 | |
| Shares traded on the day | 927.9K | |
| Beta (volatility vs the S&P 500) | 1.11 | |
| Dividends per share (last 12 months) | $3.06 | |
| Dividend yield (last 12 months) | 0.72% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings call · management outlook
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
In our pipeline, we have another 250 to 300 outpatient facilities either in our capital plan or in our acquisition plans that will come online, we believe, sometime later this year and early next year.
Samuel N. Hazen · Statement from
From what we are seeing in our resiliency plan and the visibility into the execution of that plan, And as well, if you think about the operating leverage, that we generated in second quarter from volume growth, that we believe continues, we are confident that we will be able to improve our cost trends in the back half of the year.
Michael A. Marks · Statement from
Statement dates identify the earnings call, not a deadline. Management expectations and provider estimates can change.
Read management statementsOther perspectives
Council score for HCA Healthcare (HCA): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 15, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Oct 5, 2026, except a card that shows its own read date.
Watch the HCA film — every key number, told as a short cinematic story
~2 min · open the film
What is HCA Healthcare (HCA), and what does it report?
Short answer · as of
HCA is a care-delivery network spanning acute hospitals, emergency care, surgery, imaging, rehabilitation, oncology, physician practices and psychiatric treatment.
Research dated 2026-09-12.
HCA is a care-delivery network spanning acute hospitals, emergency care, surgery, imaging, rehabilitation, oncology, physician practices and psychiatric treatment. Its revenue measures care funded through distinct payer channels, with managed care and other insurers forming the largest category and managed Medicare also carrying substantial weight.
Annual revenue advanced throughout the displayed history. Net income recovered from its trough as revenue continued rising, showing that the earnings path depends on how efficiently additional care volume passes through the network.
What do the latest results show for HCA Healthcare (HCA)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $20.23B.
Research dated 2026-09-12.
The latest period produced the highest quarterly revenue in the displayed series, while operating profit and net income improved from the immediately preceding period. Reported revenue and earnings also exceeded market estimates, continuing a run of earnings outcomes above expectations.
Those are reported outcomes. Management separately attributes prospective operating leverage to volume growth and says its resilience initiatives should improve cost trends, while the cash-flow record shows that operating cash generation remains positive but variable.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $20.23B Jun 30, 2026
- Latest quarter · SG&A
- $8.29B Jun 30, 2026
- Latest quarter · FMP standardized operating result
- $3.07B Jun 30, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Jun 30, 2026 | $20.23B | Not available | $8.29B | $3.07B |
| Mar 31, 2026 | $19.11B | Not available | $8.28B | $2.86B |
| Dec 31, 2025 | $19.51B | Not available | $0.00 | $3.18B |
| Sep 30, 2025 | $19.16B | Not available | $0.00 | $2.96B |
USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $20.23B Jul 24, 2026
- Latest report · revenue estimate
- $19.76B Jul 24, 2026
- Latest report · revenue vs estimate
- Above estimate Jul 24, 2026
- Latest report · EPS vs estimate
- Above estimate Jul 24, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Jul 24, 2026 | $20.23B | $19.76B | $7.5900 | $7.5600 |
| Apr 24, 2026 | $19.11B | $19.09B | $7.1500 | $7.1200 |
| Jan 27, 2026 | $19.51B | $19.68B | $8.0100 | $7.4600 |
| Oct 24, 2025 | $19.16B | $18.60B | $6.9600 | $5.7900 |
Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $20.23B | $1.70B | $7.62 (diluted) |
| Q1 FY2026 | $19.11B | $1.62B | $7.15 (diluted) |
| Q4 FY2025 | $19.51B | $1.88B | $8.14 (diluted) |
| Q3 FY2025 | $19.16B | $1.64B | $6.96 (diluted) |
What are the financial strengths and risks for HCA Healthcare (HCA)?
Short answer
Cash and short-term investments were $1.01B at the Jun 30, 2026 balance-sheet date. Operating cash flow was $2.33B for the quarter ended Jun 30, 2026, meaning operations generated cash. These figures do not establish a cash runway.
Research dated 2026-09-12.
Operations consistently generated cash across the displayed periods, and cash remaining after capital expenditure stayed positive despite heavy investment in facilities. That cash engine is the principal financial support for a network requiring persistent capital spending.
Debt towers over cash and investments, while short-term liquidity ratios remain below full coverage. The cash reserve also declined sharply across the reported window, even though recent balances have been comparatively stable; positive operating cash flow therefore has not translated into cash accumulation.
Payer economics and cost control meet directly in HCA’s margins. Weaker reimbursement or renewed cost pressure would become more consequential if operating cash conversion slipped while debt and capital requirements remained elevated.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $2.33B Jun 30, 2026
- Previous quarter · operating cash flow
- $2.01B Mar 31, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Jun 30, 2026 | $2.33B | −$1.23B |
| Mar 31, 2026 | $2.01B | −$1.12B |
| Dec 31, 2025 | $2.36B | −$1.49B |
| Sep 30, 2025 | $4.42B | −$1.29B |
Operating cash-flow bars share one scale and show magnitude; negative values mean cash used.
USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway.
What should you watch next at HCA Healthcare (HCA)?
Short answer · as of
The next earnings report is expected on Oct 23, 2026.
Research dated 2026-09-12.
The scheduled earnings release should be tested against the recent revenue peak, the sequential improvement in operating profit and the durability of cash remaining after capital expenditure. The important observation is not merely whether estimates are cleared, but whether revenue growth continues to produce operating leverage.
Management has linked its growth agenda to a large pipeline of outpatient facilities and its margin outlook to better cost trends. Confirmation would come from sustained volume-led profit growth without renewed cash erosion; deterioration would appear as costs outrunning revenue while capital spending and debt remain heavy.
What management is planning
Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.
In our pipeline, we have another 250 to 300 outpatient facilities either in our capital plan or in our acquisition plans that will come online, we believe, sometime later this year and early next year.
Samuel N. Hazen ·
From what we are seeing in our resiliency plan and the visibility into the execution of that plan, And as well, if you think about the operating leverage, that we generated in second quarter from volume growth, that we believe continues, we are confident that we will be able to improve our cost trends in the back half of the year.
Michael A. Marks ·
How does HCA Healthcare compare with its peers?
Short answer
HCA Healthcare's score ranks tied for 9th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-12.
HCA should not be read as merely an acute-hospital chain. Its network reaches across hospital care, freestanding emergency and surgery sites, urgent care, diagnostics, rehabilitation, oncology, physician practices and behavioral health, making outpatient expansion a core growth route rather than an incidental service.
The economic reporting lens is payer-based rather than facility-based: managed care and other insurers dominate revenue, alongside managed Medicare, traditional Medicare and Medicaid channels. Comparisons based only on hospital capacity can therefore miss the payer mix that converts clinical activity into revenue.
| Company | Price | Market value | Score |
|---|---|---|---|
| $504.73 Oct 2, 2026 | $128B | 97 5-pillar Oct 4, 2026 | |
| $175.72 Oct 2, 2026 | $10.6B | 94 5-pillar Oct 4, 2026 | |
| $11.83 Oct 2, 2026 | $4.59B | 93 5-pillar Oct 4, 2026 | |
| $61.15 Oct 2, 2026 | $125B | 91 5-pillar Oct 4, 2026 | |
| $258.62 Oct 2, 2026 | $20.8B | 89 5-pillar Oct 4, 2026 | |
| $119.80 Oct 2, 2026 | $11.9B | 89 5-pillar Oct 4, 2026 | |
| $507.50 Oct 2, 2026 | $6.63B | 87 5-pillar Oct 4, 2026 | |
| $22.25 Oct 2, 2026 | $12.0B | 84 5-pillar Oct 4, 2026 | |
| HCA Healthcare (HCA) — this page | $426.69 | $92.4B | 83 |
| $39.92 Oct 2, 2026 | $95.9B | 83 5-pillar Oct 4, 2026 | |
| $178.69 Oct 2, 2026 | $11.5B | 76 5-pillar Oct 4, 2026 | |
| $171.78 Oct 2, 2026 | $10.0B | 75 5-pillar Oct 4, 2026 | |
| $86.46 Oct 2, 2026 | $110B | 70 5-pillar Oct 4, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $369.00 – $579.00
- Consensus target
- $457.53
- Median target
- $450.00
Consensus record · Captured .
Measured against a quoted price of $426.69 (as of Oct 2, 2026).
Insider activity
Form 4 records via FMP · Of the newest 60 records, those within the last 180 days, newest dated Aug 26, 2026
- Transactions
- 11
- Identified insiders
- 10
- Purchases
- 0
- Sales
- 0
- Other transactions
- 11
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
- Institutional ownership
- 58.5% Period end Jun 30, 2026
- Previous quarter · ownership
- 58.0% Prior to period end Jun 30, 2026
- Reporting holders
- 1,400 Period end Jun 30, 2026
- Previous quarter · holders
- 1,484 Prior to period end Jun 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Blackrock, INC. | 13,003,600 |
| Vanguard Capital Management LLC | 10,141,708 |
| Sanders Capital, LLC | 8,828,287 |
| State Street Corp | 7,469,035 |
| Wellington Management Group Llp | 4,707,473 |
Quarterly filings lag the period end. Holder rows are names in the provider snapshot, not a verified ranking; individual filing dates are not supplied. Related managers may appear separately, so these positions are not summed. Holder snapshot as of Jun 30, 2026.
What has been published about HCA Healthcare (HCA)?
Common Questions About HCA (Healthcare)
Research dated 2026-09-12; the answers below are from that research, and the full attribution is under Sources. The last 3 questions are answered from this page's own dated data, not from the research.
How does HCA earn revenue from managed care patients?
HCA provides clinical services through hospitals and outpatient facilities, while managed-care organizations and other insurers fund the largest reported revenue category. Revenue therefore depends on care activity and the economics attached to the payer channel.
What does HCA’s outpatient expansion change about its hospital-centered model?
The expansion adds more entry points for surgery, emergency care, diagnostics, rehabilitation and physician services beyond the hospital campus. Management’s facility pipeline makes these settings a material route for extending the care network.
Why can HCA generate cash while its cash reserve declines?
Operating cash flow has remained positive and has exceeded capital expenditure throughout the displayed periods, yet the cash balance fell materially across the broader window. Cash generation from operations therefore does not describe every use of capital affecting the reserve.
Did HCA’s latest revenue gain strengthen operating profit?
Quarterly revenue reached the high point of the displayed series, and operating profit improved from the preceding period. Management says volume growth created operating leverage, while continued cost improvement remains an execution test.
What is the HCA stock price today?
The last price recorded on this page for HCA Healthcare, Inc. (HCA) is $426.69, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the HCA price target?
The analyst consensus price target for HCA Healthcare, Inc. (HCA) is $457.53 (range $369.00 to $579.00, median $450.00), per FMP data captured Oct 4, 2026. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
When are HCA's next earnings?
The next earnings date listed on this page for HCA Healthcare, Inc. (HCA) is Oct 23, 2026. Companies sometimes move report dates, so the company's own announcement is the final word on timing.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (80 figures)
The 80 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
OFFICIAL — 2 facts from SEC filings and earnings calls
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
prod.outlook | Management outlook — call excerpts | Samuel N. Hazen (Jul 24, 2026): In our pipeline, we have another 250 to 300 outpatient facilities either in our capital plan or in our acquisition plans that will come online, we believe, sometime later this year and early next year. Michael A. Marks (Jul 24, 2026): From what we are seeing in our resiliency plan and the visibility into the execution of that plan, And as well, if you think about the operating leverage, that we generated in second quarter from volume growth, that we believe continues, we are confident that we will be able to improve our cost trends in the back half of the year. | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) — Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | |
id.hq | SEC filing business address | ONE Park PLZ, Nashville, TN, 37203 | OFFICIAL | SEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "One Park Plaza, Nashville, TN, 37203, US". |
FMP — 68 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $426.69 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-04T12:34:37.930Z. | |
px.change | Change on the day | +0.78% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $92.4B | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:02.000Z. Captured from FMP at 2026-10-04T12:34:36.972Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
px.change_abs | Change on the day, in dollars | +$3.30 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2026 | $20.23B | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
px.pe | Price / earnings (trailing) | 14.24 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 927.9K | FMP | Financial Modeling Prep (FMP) · quote | |
px.beta | Beta | 1.11 | FMP | Financial Modeling Prep (FMP) company profile | |
id.ceo | Chief executive | Samuel N. Hazen | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
id.founder | Founder named in the filing | Thomas F. Frist Jr. — Founder & Chairman Emeritus | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
id.employees | Employees | 320,000 | FMP | Financial Modeling Prep (FMP) employee count, from the company's filing | |
fin.annual | Revenue and net result by fiscal year | 5 fiscal years, FY2021 through FY2025: FY2021 revenue $58.75B, net result $6.96B; FY2022 revenue $60.23B, net result $5.64B; FY2023 revenue $64.97B, net result $5.24B; FY2024 revenue $70.60B, net result $5.76B; FY2025 revenue $75.60B, net result $6.78B | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements | |
fin.rev_mix | Reported revenue segments | Medicaid $5.91B · Medicare $11.27B · Managed Medicaid $3.69B · Managed Medicare $13.44B · Managed Care And Other Insurers $36.97B | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K | |
fin.gross_margin | Gross margin (trailing twelve months) | 28.4% | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
fin.q_table.depth.2026-06-30.revenue_k | Revenue — period end 2026-06-30 | $20.23B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.sga_k | SG&A — period end 2026-06-30 | $8.29B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.operating_result_k | FMP standardized operating result — period end 2026-06-30 | $3.07B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.revenue_k | Revenue — period end 2026-03-31 | $19.11B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.sga_k | SG&A — period end 2026-03-31 | $8.28B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.operating_result_k | FMP standardized operating result — period end 2026-03-31 | $2.86B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.revenue_k | Revenue — period end 2025-12-31 | $19.51B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.sga_k | SG&A — period end 2025-12-31 | $0.00 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.operating_result_k | FMP standardized operating result — period end 2025-12-31 | $3.18B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.revenue_k | Revenue — period end 2025-09-30 | $19.16B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.sga_k | SG&A — period end 2025-09-30 | $0.00 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.operating_result_k | FMP standardized operating result — period end 2025-09-30 | $2.96B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
earn.history.depth.2026-07-24.revenue_actual | Revenue · reported — report date 2026-07-24 | $20.23B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-24.revenue_estimated | Revenue · estimate — report date 2026-07-24 | $19.76B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-24.eps_actual | EPS · reported — report date 2026-07-24 | $7.5900 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-24.eps_estimated | EPS · estimate — report date 2026-07-24 | $7.5600 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-24.revenue_actual | Revenue · reported — report date 2026-04-24 | $19.11B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-24.revenue_estimated | Revenue · estimate — report date 2026-04-24 | $19.09B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-24.eps_actual | EPS · reported — report date 2026-04-24 | $7.1500 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-24.eps_estimated | EPS · estimate — report date 2026-04-24 | $7.1200 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-01-27.revenue_actual | Revenue · reported — report date 2026-01-27 | $19.51B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-01-27.revenue_estimated | Revenue · estimate — report date 2026-01-27 | $19.68B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-01-27.eps_actual | EPS · reported — report date 2026-01-27 | $8.0100 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-01-27.eps_estimated | EPS · estimate — report date 2026-01-27 | $7.4600 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-24.revenue_actual | Revenue · reported — report date 2025-10-24 | $19.16B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-24.revenue_estimated | Revenue · estimate — report date 2025-10-24 | $18.60B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-24.eps_actual | EPS · reported — report date 2025-10-24 | $6.9600 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-24.eps_estimated | EPS · estimate — report date 2025-10-24 | $5.7900 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
fin.cash_investments | Cash and short-term investments | $1.01B | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. | |
fin.opcf_latest | Latest-quarter operating cash flow | $2.33B | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Period end: 2026-06-30. Negative operating cash flow means cash used. This figure is not a cash-runway estimate. | |
fin.long_term_investments | Long-term investments (classification unverified) | $813.00M | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.total_debt | Total debt | $48.78B | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.opcf.depth.2026-06-30.operating_cash_flow_m | Operating cash flow — period end 2026-06-30 | $2.33B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-03-31.operating_cash_flow_m | Operating cash flow — period end 2026-03-31 | $2.01B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-06-30.capex_m | Capital expenditure (reported) — period end 2026-06-30 | −$1.23B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-03-31.capex_m | Capital expenditure (reported) — period end 2026-03-31 | −$1.12B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-12-31.operating_cash_flow_m | Operating cash flow — period end 2025-12-31 | $2.36B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-12-31.capex_m | Capital expenditure (reported) — period end 2025-12-31 | −$1.49B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-09-30.operating_cash_flow_m | Operating cash flow — period end 2025-09-30 | $4.42B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-09-30.capex_m | Capital expenditure (reported) — period end 2025-09-30 | −$1.29B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
earn.pt_range | Analyst price target, low to high | $369.00 – $579.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
earn.pt_consensus | Consensus analyst price target | $457.53 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
earn.pt_median | Median analyst price target | $450.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
own.insiders | Insider transactions via FMP | 11 transactions · 0 purchases, 0 sales, 11 other transactions · 10 identified insiders · of the newest 60 records, those within the last 180 days, newest dated Aug 26, 2026 | FMP | Financial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent. | |
own.institutions.depth.ownership_pct | Institutional ownership | 58.5% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.ownership_pct_previous_quarter | Previous quarter · ownership | 58.0% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.institutions.depth.holders | Reporting holders | 1,400 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.holders_previous_quarter | Previous quarter · holders | 1,484 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.top_holders.depth.holder_0.shares | Blackrock, INC. — shares in provider snapshot | 13,003,600 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_1.shares | Vanguard Capital Management LLC — shares in provider snapshot | 10,141,708 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_2.shares | Sanders Capital, LLC — shares in provider snapshot | 8,828,287 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_3.shares | State Street Corp — shares in provider snapshot | 7,469,035 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_4.shares | Wellington Management Group Llp — shares in provider snapshot | 4,707,473 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. |
UNRECORDED — 3 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.next | Next earnings date | Oct 23, 2026 | UNRECORDED | Stored earnings-calendar observation — Captured 2026-07-27 | |
earn.history | Reported versus estimated, recent quarters | EPS beat 5 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-10-03 | |
px.range52 | 52-week range | $353.99 – $556.52 | UNRECORDED | Stored company-profile observation — Captured 2026-10-03 |
COMPUTED — 5 facts from our arithmetic, formula restated
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
fin.mcap_to_cash | Market value per dollar of cash and short-term investments | 91.21× | — | COMPUTED | Computed on this page from the figures above — The market capitalisation printed on this page divided by cash and short-term investments of $1.01B at Jun 30, 2026. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. Market cap record date: 2026-10-02. Balance-sheet reference date: 2026-06-30. The inputs do not establish a single common source date for this ratio. |
div.ttm_per_share | Dividends per share, last 12 months (split-adjusted) | $3.06 | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history — Sum of 4 split-adjusted declared dividends with an ex-date in the 365 days to 2026-10-04, per current share. Ex-dates are not payment dates; special dividends are included. Not a declared annual rate. | |
div.ttm_yield | Dividend yield, last 12 months | 0.72% | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history and quote — Split-adjusted dividends with ex-dates in the trailing 365-day window divided by the packet price, on the same current-share basis. Price date follows the quote, latest price bar or packet-build day when unstamped. Not a forecast or declared annual rate. | |
earn.history.depth.2026-07-24.revenue_actual.comparison | Latest report · revenue vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported revenue ($20.23B) with the recorded estimate ($19.76B) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
earn.history.depth.2026-07-24.eps_actual.comparison | Latest report · EPS vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported EPS ($7.5900) with the recorded estimate ($7.5600) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
OURS — 2 facts from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
ours.moonshot | MoonshotScore v2 | 83 of 100 · Exceptional · pillars 78 / 59 / 80 / 94 / 65 | OURS | Stock Expert AI MoonshotScore v2 engine | |
ours.moonshot_change | MoonshotScore movement | 83 (stored snapshot Oct 3, 2026) → 83 (current publication computed Oct 4, 2026) (0) | OURS | Stock Expert AI current score publication and immutable score snapshots |
Fact-family notes
- Quarterly statement note. Source series as of 2026-06-30. USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow. Applies to Fact IDs:
fin.q_table.depth.2026-06-30.revenue_k,fin.q_table.depth.2026-06-30.sga_k,fin.q_table.depth.2026-06-30.operating_result_k,fin.q_table.depth.2026-03-31.revenue_k,fin.q_table.depth.2026-03-31.sga_k,fin.q_table.depth.2026-03-31.operating_result_k,fin.q_table.depth.2025-12-31.revenue_k,fin.q_table.depth.2025-12-31.sga_k,fin.q_table.depth.2025-12-31.operating_result_k,fin.q_table.depth.2025-09-30.revenue_k,fin.q_table.depth.2025-09-30.sga_k,fin.q_table.depth.2025-09-30.operating_result_k. - Earnings-history note. Source series as of 2026-07-24. Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined. Applies to Fact IDs:
earn.history.depth.2026-07-24.revenue_actual,earn.history.depth.2026-07-24.revenue_estimated,earn.history.depth.2026-07-24.revenue_actual.comparison,earn.history.depth.2026-07-24.eps_actual.comparison,earn.history.depth.2026-07-24.eps_actual,earn.history.depth.2026-07-24.eps_estimated,earn.history.depth.2026-04-24.revenue_actual,earn.history.depth.2026-04-24.revenue_estimated,earn.history.depth.2026-04-24.eps_actual,earn.history.depth.2026-04-24.eps_estimated,earn.history.depth.2026-01-27.revenue_actual,earn.history.depth.2026-01-27.revenue_estimated,earn.history.depth.2026-01-27.eps_actual,earn.history.depth.2026-01-27.eps_estimated,earn.history.depth.2025-10-24.revenue_actual,earn.history.depth.2025-10-24.revenue_estimated,earn.history.depth.2025-10-24.eps_actual,earn.history.depth.2025-10-24.eps_estimated. - Cash-flow note. Source series as of 2026-06-30. USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway. Applies to Fact IDs:
fin.opcf.depth.2026-06-30.operating_cash_flow_m,fin.opcf.depth.2026-03-31.operating_cash_flow_m,fin.opcf.depth.2026-06-30.capex_m,fin.opcf.depth.2026-03-31.capex_m,fin.opcf.depth.2025-12-31.operating_cash_flow_m,fin.opcf.depth.2025-12-31.capex_m,fin.opcf.depth.2025-09-30.operating_cash_flow_m,fin.opcf.depth.2025-09-30.capex_m.
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources used for research written 2026-09-12
Historical evidence preserved with this analysis. Current figures are listed separately above.
| Evidence | Captured value | Source date | Source type | Source |
|---|---|---|---|---|
| Business description | HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee. | 2026-09-12 | FMP | Financial Modeling Prep (FMP) company profile |
| Revenue by segment | Medicaid: $5.91B; Medicare: $11.27B; Managed Medicaid: $3.69B; Managed Medicare: $13.44B; Managed Care And Other Insurers: $36.97B | 2025-12-31 | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K |
| Quarterly income statement (USD thousands) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements |
| Cash, investments and debt | Total debt: $48.78B; Liquidity basis: cash and short-term investments; Total liabilities: $63.67B; Cash and short-term investments: $1.01B; Cash and investments: $1.83B; Long-term investments: $813.00M; Long-term investments classification: unclassified Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's balance sheet |
| Management outlook — dated call excerpts | Captured record · 2 entries
Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | 2026-07-24 | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) |
| Annual revenue and net result (USD millions) | Captured record · 5 entries
| 2025-12-31 | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements |
| Reported versus estimated, last 8 quarters | Captured record · 8 entries
| 2026-07-24 | FMP | Financial Modeling Prep (FMP) earnings |
| Operating cash flow by quarter (USD millions) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements |
| Cash and investment components | Total basis: cash short and long-term investments; Total: $1.83B; Cash and short-term investments: $1.01B; Long-term investments: $813.00M; Long-term investments classification: unclassified Sums the balance sheet's cash and short-term investments with its long-term investments.; The long-term investment field does not establish marketability; the sum is not a measure of available liquidity.; These provider fields do not establish investment access restrictions or explain differences from third-party cash figures. | 2026-06-30 | COMPUTED | Computed from the balance sheet |
| Cash and short-term investments over time (USD millions) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's quarterly balance sheets |
| Cash decline over the reported window | To: 2026-06-30; From: 2024-09-30; Periods: 7; Cash basis: cash and short-term investments; Closing balance: $1.01B; Decline: $1.88B; Opening balance: $2.89B; Average change per period: $267.90M Change in cash, cash equivalents and short-term investments between the 2024-09-30 and 2026-06-30 balance sheets.; This is a balance change, not operating burn: financing and investing move it too.; Averaged over 7 reporting periods of unequal length. | 2026-06-30 | COMPUTED | Computed from reported balances |
| Cash against market value | As of: 2026-06-30; Cash basis: cash and short-term investments; Net cash: -$47.76B; Total debt: $48.78B; Cash and investments: $1.01B Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. Cash is the latest reported cash and short-term investment balance; long-term investments are excluded. Market capitalization is the latest provider value.; The reported balance does not establish unrestricted availability or liquidation value.; The two are measured on different dates — the balance sheet is a quarter-end, the market cap is a recent close.; Debt is total debt as reported, including operating lease liabilities where the filer includes them. | 2026-06-30 | COMPUTED | Computed from the balance sheet and the latest market capitalization |
| Trailing twelve-month ratio set | Quick ratio: 0.69; Current ratio: 0.78; Debt to equity: -7.42; Net margin: 8.8%; Gross margin: 28.4%; Operating margin: 15.5%; Return on assets: 11.3%; Return on equity: -112.9% Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. A ratio our provider could not compute is absent rather than shown as zero. | 2026-09-12 | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm |
| Next earnings report | Date: 2026-10-23; EPS estimate: $6.71 per share; Revenue estimate: $19.35B The date is our provider's estimate until the company confirms it. | 2026-09-12 | FMP | Financial Modeling Prep (FMP) earnings calendar |
| Analyst revenue and earnings estimates (average) | Captured record · 4 entries
| 2026-09-12 | FMP | Financial Modeling Prep (FMP) analyst estimates |
Data provided for informational purposes only.
ETFs that hold HCA
Funds in our ETF coverage that list HCA among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| SMI 3Fourteen Full-Cycle Trend ETF (FCTE) | 5.39% | |
| IHF ETF | 5.28% | |
| FLDZ ETF | 0.51% |